KK

Kollipara Koteswara Rao

Active Director Managing Director DIN 02287235
DIN 02287235 First appointment Jul 2008 Primary industry Life Sciences
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 4 historical roles
Total affiliations 7 Since Jul 2008
Shareholding value •••• Premium profile

About Kollipara Koteswara Rao

Data last updated:

Kollipara Koteswara Rao is a Managing Director at Transgene Biotek Limited (since 2020), Director at Niedlfree Technologies Private Limited (since 2021) and Director at Neodel Pharma Private Limited (since 2021). The companies operate in Life Sciences, Healthcare and Biotechnology. The 2 current companies with reported revenue have a combined latest revenue of ₹1.23 Cr; the largest is Transgene Biotek Limited at ₹1.04 Cr (FY 2025). Earlier, Kollipara Koteswara Rao was a Director at Strategene Biotech Private Limited (2013–2015) and Director at Peroral Bio Private Limited (from 2020) and 2 more.

DIN 02287235
Primary Designation Managing Director
Industry Life Sciences
First Appointment 31 Jul 2008
Oldest Company Age 36 yrs
Largest company Transgene Biotek Limited · ₹1.04 Cr (FY 2025)
Combined revenue ₹1.23 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Transgene Biotek Limited L85195TG1990PLC011065
Managing Director04 Mar 20201990₹1.04 Cr (FY 2025)Active
Director21 Sep 20212021₹18.8 Lakh (FY 2025)Active
Neodel Pharma Private Limited U24299TG2021PTC149719
Director17 Mar 20212021Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Strategene Biotech Private Limited U24248TG2013PTC085798
Director15 Feb 20132013Strike Off
Peroral Bio Private Limited U24230TG2020PTC147169
Director23 Dec 20202020Strike Off
Diamond Life Properties Limited U45200TG2008PLC057489
Director31 Jul 20082008Strike Off
Director31 Jul 20082008Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Peroral Bio Private Limited
Neodel Pharma Private Limited
Diamond Life Properties Limited
Niedlfree Technologies Private Limited
Premium access

Shareholding and investment profile for Kollipara Koteswara Rao

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kollipara Koteswara Rao

Kollipara Koteswara Rao currently holds 3 directorships: Transgene Biotek Limited (Managing Director, since 04 Mar 2020, revenue ₹1.04 Cr (FY 2025)); Niedlfree Technologies Private Limited (Director, since 21 Sep 2021, revenue ₹18.8 Lakh (FY 2025)); Neodel Pharma Private Limited (Director, since 17 Mar 2021).

Kollipara Koteswara Rao was first appointed on 31 Jul 2008 as Director at Diamond Life Properties Limited. The most recent appointment on record is 21 Sep 2021 at Niedlfree Technologies Private Limited.

The 2 current companies of Kollipara Koteswara Rao that report revenue have a combined latest revenue of ₹1.23 Cr: Transgene Biotek Limited ₹1.04 Cr (FY 2025); Niedlfree Technologies Private Limited ₹18.8 Lakh (FY 2025).

Kollipara Koteswara Rao held 4 earlier board appointments: Strategene Biotech Private Limited (Director, 15 Feb 2013 to 04 Dec 2015); Peroral Bio Private Limited (Director, from 23 Dec 2020); Diamond Life Properties Limited (Director, from 31 Jul 2008); Diamond Life Pan India Properties Limited (Director, from 31 Jul 2008).

The current boards of Kollipara Koteswara Rao's companies include Ankita Jain (Transgene Biotek Limited), Chowdari Prasad (Transgene Biotek Limited), Santhosh Kumar (Transgene Biotek Limited), Sujana Kadiam (Transgene Biotek Limited), Swetha Marri (Transgene Biotek Limited), Jeetendra Ambulge Kashinath (Niedlfree Technologies Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available